Moderna
MRNA
23,16 €
Share price
-2.09%
Change (1 day)
-76.30%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.
Moderna (MRNA) - P/B ratio
P/B ratio as of April 2025 : 0.9306
According to Moderna
's latest financial reports the company has a price-to-book ratio of 3.1713.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Moderna - P/B ratio (from 2018 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | 1.42 | -48.24% |
| 2023-12-31 | 2.74 | -24.15% |
| 2022-12-31 | 3.61 | -50.43% |
| 2021-12-31 | 7.28 | -54.9% |
| 2020-12-31 | 16.1 | 188.09% |
| 2019-12-31 | 5.60 | 70.78% |
| 2018-12-31 | 3.28 | |
| 2017-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | P/B ratio differencediff. | Country |
|---|---|---|---|
 | 1.69 | 81.66% | 🇺🇸 USA |
 | 4.25 | 357.09% | 🇺🇸 USA |
 | -0.0229 | -102.46% | 🇺🇸 USA |
 | 446 | 47,771.32% | 🇺🇸 USA |
 | 4.92 | 428.72% | 🇨🇭 Switzerland |
 | 31.5 | 3,286.48% | 🇺🇸 USA |
 | 5.18 | 456.43% | 🇺🇸 USA |